Cathie's Ark LogoCathie's Ark
Trading Floor Community IconFrom the Trading Floor:
Editas Medicine Inc Logo

ARKG Holdings of Editas Medicine (EDIT) - Updated Daily

Lock Icon
Date
Direction
Shares
Fund Weight
Fund
August 17, 2021BUY290000.0212%ARKG
August 3, 2021BUY350000.0168%ARKG
August 2, 2021BUY303560.0147%ARKG
December 22, 2020SELL1687600.1914%ARKG
December 21, 2020SELL377000.0479%ARKG
  • 1
  • 2
  • 5 / page

Key Statistics

🕵🏼Found In🏷Last Price
ARKGARKK$60.79
⚖️Weighting🧢Market Cap
1.02%$4.15b
🏋🏿‍♂️Weight Rank In ARKG🧮Price to Sales
3951.14
🏋️‍♀️Weight Rank Across All Funds🌏Country
31🇺🇸United States
💳ARK Estimated Cost Average🎫ARK Ownership Percent
$29.861.9%
Description
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.
Website
www.editasmedicine.com

Research Notes and Commentary for EDIT